MXPA03009206A - FORMULACIONES DE 3,7-DIAZABICICLO [3.3.1] COMO COMPUESTOS ANTIARRiTMICOS. - Google Patents

FORMULACIONES DE 3,7-DIAZABICICLO [3.3.1] COMO COMPUESTOS ANTIARRiTMICOS.

Info

Publication number
MXPA03009206A
MXPA03009206A MXPA03009206A MXPA03009206A MXPA03009206A MX PA03009206 A MXPA03009206 A MX PA03009206A MX PA03009206 A MXPA03009206 A MX PA03009206A MX PA03009206 A MXPA03009206 A MX PA03009206A MX PA03009206 A MXPA03009206 A MX PA03009206A
Authority
MX
Mexico
Prior art keywords
antiarhythmic
diazabicyclo
formulations
compounds
antiarhythmic compounds
Prior art date
Application number
MXPA03009206A
Other languages
English (en)
Inventor
Annika Bjoere
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of MXPA03009206A publication Critical patent/MXPA03009206A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
MXPA03009206A 2001-04-12 2002-04-12 FORMULACIONES DE 3,7-DIAZABICICLO [3.3.1] COMO COMPUESTOS ANTIARRiTMICOS. MXPA03009206A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0101327A SE0101327D0 (sv) 2001-04-12 2001-04-12 New crystalline forms
PCT/SE2002/000725 WO2002083688A1 (en) 2001-04-12 2002-04-12 3,7-diazabicyclo [3.3.1] formulations as antiarhythmic compounds

Publications (1)

Publication Number Publication Date
MXPA03009206A true MXPA03009206A (es) 2004-01-29

Family

ID=20283783

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03009206A MXPA03009206A (es) 2001-04-12 2002-04-12 FORMULACIONES DE 3,7-DIAZABICICLO [3.3.1] COMO COMPUESTOS ANTIARRiTMICOS.

Country Status (30)

Country Link
US (1) US7217708B2 (es)
EP (2) EP1389213B1 (es)
JP (1) JP2004525970A (es)
KR (1) KR20030087078A (es)
CN (1) CN1269823C (es)
AR (1) AR035452A1 (es)
AT (1) ATE323095T1 (es)
BR (1) BR0208829A (es)
CA (1) CA2443470A1 (es)
CZ (1) CZ20032760A3 (es)
DE (1) DE60210598T2 (es)
DK (1) DK1389213T3 (es)
EE (1) EE200300504A (es)
ES (1) ES2261721T3 (es)
HK (1) HK1061026A1 (es)
HU (1) HUP0303487A3 (es)
IL (1) IL158250A0 (es)
IS (1) IS6980A (es)
MX (1) MXPA03009206A (es)
NO (1) NO20034527L (es)
NZ (1) NZ528560A (es)
PL (1) PL367179A1 (es)
PT (1) PT1389213E (es)
RU (1) RU2286993C2 (es)
SE (1) SE0101327D0 (es)
SK (1) SK12572003A3 (es)
TW (1) TWI237025B (es)
UA (1) UA74629C2 (es)
WO (1) WO2002083688A1 (es)
ZA (1) ZA200307759B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI259836B (en) * 2001-04-12 2006-08-11 Astrazeneca Ab Modified release formulation suitable for antiarrhythmic compounds
SE0401540D0 (sv) * 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
SE0401539D0 (sv) * 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
WO2006135316A1 (en) * 2005-06-13 2006-12-21 Astrazeneca Ab New oxabispidine compounds for the treatment of cardiac arrhythmias
AR057363A1 (es) * 2005-06-20 2007-11-28 Astrazeneca Ab Proceso para la preparacion de oxabispidinas n,n'-disustituidas
WO2006137772A1 (en) * 2005-06-20 2006-12-28 Astrazeneca Ab New physical form of n,n´- disubstituted oxabispidines
TW200734342A (en) * 2005-12-15 2007-09-16 Astrazeneca Ab New compounds for the treatment of cardiac arrhythmias
JP2009529539A (ja) * 2006-03-07 2009-08-20 エンダセア, インコーポレイテッド 呼吸器障害を治療するための方法および組成物
EP3026044B8 (en) 2006-06-26 2018-12-19 Akebia Therapeutics, Inc. Prolyl hydroxylase inhibitors and methods of use
WO2012170439A1 (en) 2011-06-06 2012-12-13 The Ohio State University Methods for stabilizing hypoxia inducible factor-2 alpha as a method for treating cancer
NO2686520T3 (es) 2011-06-06 2018-03-17
CN114404414A (zh) 2013-06-13 2022-04-29 阿克比治疗有限公司 用于治疗贫血症的组合物和方法
AR099354A1 (es) 2013-11-15 2016-07-20 Akebia Therapeutics Inc Formas sólidas de ácido {[5-(3-clorofenil)-3-hidroxipiridin-2-carbonil]amino}acético, composiciones, y sus usos
WO2016118858A1 (en) 2015-01-23 2016-07-28 Akebia Therapeutics, Inc. Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof
BR112017021097B1 (pt) 2015-04-01 2024-01-02 Akebia Therapeutics, Inc Formulação de dosagem oral e seu uso
TWI822776B (zh) 2018-05-09 2023-11-21 美商阿克比治療有限公司 用於製備2-[[5-(3-氯苯基)-3-羥基吡啶-2-羰基]胺基]乙酸之方法
US11524939B2 (en) 2019-11-13 2022-12-13 Akebia Therapeutics, Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3732094A1 (de) * 1987-09-24 1989-04-06 Basf Ag Bispidinderivate als klasse iii-antiarrhythmika
US5110933A (en) * 1989-11-13 1992-05-05 Board Of Regents Of Oklahoma State University Salts of 3-azabicyclo[3.3.1]nonanes as antiarrhythmic agents, and precursors thereof
SE9704709D0 (sv) * 1997-12-17 1997-12-17 Astra Ab Pharmaceutically active compounds
SE9902268D0 (sv) 1999-06-16 1999-06-16 Astra Ab Pharmaceutically active compounds
SE9903759D0 (sv) * 1999-10-18 1999-10-18 Astra Ab Pharmaceutically active compounds

Also Published As

Publication number Publication date
US7217708B2 (en) 2007-05-15
DE60210598T2 (de) 2007-02-08
EP1389213A1 (en) 2004-02-18
RU2003129231A (ru) 2005-04-10
NZ528560A (en) 2005-05-27
JP2004525970A (ja) 2004-08-26
TWI237025B (en) 2005-08-01
ZA200307759B (en) 2005-01-03
DE60210598D1 (de) 2006-05-24
UA74629C2 (en) 2006-01-16
HUP0303487A3 (en) 2005-04-28
CN1514837A (zh) 2004-07-21
EP1389213B1 (en) 2006-04-12
ES2261721T3 (es) 2006-11-16
ATE323095T1 (de) 2006-04-15
SK12572003A3 (sk) 2004-07-07
PT1389213E (pt) 2006-07-31
EE200300504A (et) 2003-12-15
WO2002083688A1 (en) 2002-10-24
RU2286993C2 (ru) 2006-11-10
AR035452A1 (es) 2004-05-26
KR20030087078A (ko) 2003-11-12
SE0101327D0 (sv) 2001-04-12
HK1061026A1 (en) 2004-09-03
EP1550663A1 (en) 2005-07-06
CA2443470A1 (en) 2002-10-24
CZ20032760A3 (cs) 2004-01-14
US20040143000A1 (en) 2004-07-22
DK1389213T3 (da) 2006-07-10
IS6980A (is) 2003-10-08
PL367179A1 (en) 2005-02-21
NO20034527L (no) 2003-12-10
IL158250A0 (en) 2004-05-12
CN1269823C (zh) 2006-08-16
BR0208829A (pt) 2004-03-09
NO20034527D0 (no) 2003-10-09
HUP0303487A2 (hu) 2004-01-28

Similar Documents

Publication Publication Date Title
AP2002002695A0 (en) Pyrrolo Ä2,3-dÜpyrimidine compounds
HK1051193A1 (en) (1,4')-Bipiperidine compounds.
IL160708A0 (en) 1, 6-naphthyridine derivatives as antidiabetics
MXPA03009558A (es) Compuestos novedosos.
MXPA03008275A (es) Formulas antibacteriales.
AU4787301A (en) 26,27-homologated-20-epi-2-alkyl-19-nor-vitamin d compounds
PL367179A1 (en) 3,7-diazabicyclo [3.3.1] formulations as antiarhythmic compounds
HK1069171A1 (en) Substituted 6H-dibenzioÄc,hÜchromenes as estrogenic agents.
MXPA03007693A (es) Composicion para la piel.
ZA200206779B (en) Solid formulation.
ZA200207341B (en) Novel 2,3,4,5-tetrahydro-1H-[1,4]diazepino[1,7a]indole compounds.
EG23378A (en) Composition.
MXPA03009209A (es) Formulaciones de 3,7-diazabiciclo-[3.3.1] como compuestos anti-arritmicos.
MXPA03001263A (es) Formulacion fungicida.
IL162310A0 (en) 3,4-Dihydro-1h-isoquinoloin-2-yl-derivatives
IL158035A0 (en) 3, 7-diazabicyclo [3.3.1] formulations as antiarrhythmic compounds
ZA200403323B (en) Anthelmintic composition.
MXPA01000464A (es) Composicion.
MXPA03008077A (es) Composicion humedecedora para la piel..
SI1389213T1 (sl) 3,7-diazabiciklo(3.3.1)formulacije kot antiaritmicne spojine
SI1497256T1 (sl) Substituirane 1,5-diaminopentan-3-olne spojine
IL159965A0 (en) Novel 2,4-diaminothiazole derivatives
PL352760A1 (en) Oxathiepino[6,5-b
MXPA03006632A (es) Composicion solida.
ZA200108301B (en) Anthelmintic composition.

Legal Events

Date Code Title Description
FG Grant or registration